1 |
ADRA2A
💬
| 4件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Dexmedetomidine hydrochloride
Dexmedetomidine hydrochloride
💬
|
Dexmedetomidine
| 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
2 |
ADRA2A
💬
| 4件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Dexmedetomidine
Dexmedetomidine
💬
|
Dexmedetomidine
| 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
3 |
ADRA2B
💬
| 4件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Dexmedetomidine hydrochloride
Dexmedetomidine hydrochloride
💬
|
Dexmedetomidine
| 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
4 |
ADRA2B
💬
| 4件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Dexmedetomidine
Dexmedetomidine
💬
|
Dexmedetomidine
| 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
5 |
ADRA2C
💬
| 4件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Dexmedetomidine hydrochloride
Dexmedetomidine hydrochloride
💬
|
Dexmedetomidine
| 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
6 |
ADRA2C
💬
| 4件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Dexmedetomidine
Dexmedetomidine
💬
|
Dexmedetomidine
| 15件: 2 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
|
7 |
ADRB1
💬
| 13件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | Metoprolol tartrate
Metoprolol tartrate
💬
|
Metoprolol
| 6件: 17 17, 57, 58, 113, 193, 226 💬
|
8 |
ADRB1
💬
| 13件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | Metoprolol succinate
Metoprolol succinate
💬
|
Metoprolol
| 6件: 17 17, 57, 58, 113, 193, 226 💬
|
9 |
ADRB1
💬
| 13件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | Metoprolol fumarate
Metoprolol fumarate
💬
|
Metoprolol
| 6件: 17 17, 57, 58, 113, 193, 226 💬
|
10 |
ADRB1
💬
| 13件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | Metoprolol
Metoprolol
💬
|
Metoprolol
| 6件: 17 17, 57, 58, 113, 193, 226 💬
|
11 |
ADRB3
💬
| 9件: Calcium signaling pathway Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | Mirabegron
Mirabegron
💬
|
Mirabegron
| 4件: 6 6, 13, 53, 226 💬
|
12 |
CACNA1C
💬
| 34件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Propiverine hydrochloride
Propiverine hydrochloride
💬
|
Propiverine
| 1件: 226 226 💬
|
13 |
CACNA1C
💬
| 34件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Propiverine
Propiverine
💬
|
Propiverine
| 1件: 226 226 💬
|
14 |
CACNA1D
💬
| 35件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cellular senescence, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Tight junction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Carbohydrate digestion and absorption, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Propiverine
Propiverine
💬
|
Propiverine
| 1件: 226 226 💬
|
15 |
CACNA1D
💬
| 35件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cellular senescence, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Tight junction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome, Growth hormone synthesis, secretion and action, Carbohydrate digestion and absorption, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Propiverine hydrochloride
Propiverine hydrochloride
💬
|
Propiverine
| 1件: 226 226 💬
|
16 |
CACNA1F
💬
| 27件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Propiverine
Propiverine
💬
|
Propiverine
| 1件: 226 226 💬
|
17 |
CACNA1F
💬
| 27件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Propiverine hydrochloride
Propiverine hydrochloride
💬
|
Propiverine
| 1件: 226 226 💬
|
18 |
CACNA1S
💬
| 27件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Propiverine hydrochloride
Propiverine hydrochloride
💬
|
Propiverine
| 1件: 226 226 💬
|
19 |
CACNA1S
💬
| 27件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Renin secretion, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome, Growth hormone synthesis, secretion and action, Alzheimer disease, Prion disease, Pathways of neurodegeneration - multiple diseases, Chemical carcinogenesis - receptor activation, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy | Propiverine
Propiverine
💬
|
Propiverine
| 1件: 226 226 💬
|
20 |
CALC
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Vascular smooth muscle contraction | Galcanezumab
Galcanezumab
💬
|
Galcanezumab
| 1件: 226 226 💬
|
21 |
CALC
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Vascular smooth muscle contraction | Fremanezumab
Fremanezumab
💬
|
Fremanezumab
| 2件: 124 124, 226 💬
|
22 |
CALC
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Vascular smooth muscle contraction | Eptinezumab
Eptinezumab
💬
|
Eptinezumab
| 1件: 226 226 💬
|
23 |
CALCRL
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction | Ubrogepant
Ubrogepant
💬
|
Ubrogepant
| 1件: 226 226 💬
|
24 |
CALCRL
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction | Rimegepant
Rimegepant
💬
|
Rimegepant
| 1件: 226 226 💬
|
25 |
CALCRL
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction | Rimegepant sulfate
Rimegepant sulfate
💬
|
Rimegepant
| 1件: 226 226 💬
|
26 |
CALCRL
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction | Erenumab
Erenumab
💬
|
Erenumab
| 1件: 226 226 💬
|
27 |
CALCRL
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction | Atogepant
Atogepant
💬
|
Atogepant
| 1件: 226 226 💬
|
28 |
CHRM1
💬
| 9件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Propiverine hydrochloride
Propiverine hydrochloride
💬
|
Propiverine
| 1件: 226 226 💬
|
29 |
CHRM1
💬
| 9件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Propiverine
Propiverine
💬
|
Propiverine
| 1件: 226 226 💬
|
30 |
CHRM2
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton | Propiverine hydrochloride
Propiverine hydrochloride
💬
|
Propiverine
| 1件: 226 226 💬
|
31 |
CHRM2
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton | Propiverine
Propiverine
💬
|
Propiverine
| 1件: 226 226 💬
|
32 |
CHRM3
💬
| 12件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Propiverine hydrochloride
Propiverine hydrochloride
💬
|
Propiverine
| 1件: 226 226 💬
|
33 |
CHRM3
💬
| 12件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Taste transduction, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Propiverine
Propiverine
💬
|
Propiverine
| 1件: 226 226 💬
|
34 |
CHRM4
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Regulation of actin cytoskeleton | Propiverine
Propiverine
💬
|
Propiverine
| 1件: 226 226 💬
|
35 |
CHRM4
💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Regulation of actin cytoskeleton | Propiverine hydrochloride
Propiverine hydrochloride
💬
|
Propiverine
| 1件: 226 226 💬
|
36 |
CHRM5
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Propiverine hydrochloride
Propiverine hydrochloride
💬
|
Propiverine
| 1件: 226 226 💬
|
37 |
CHRM5
💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Cholinergic synapse, Regulation of actin cytoskeleton, Alzheimer disease, Pathways of neurodegeneration - multiple diseases | Propiverine
Propiverine
💬
|
Propiverine
| 1件: 226 226 💬
|
38 |
CNR1
💬
| 4件: Rap1 signaling pathway Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling | Cannabidiol
Cannabidiol
💬
|
Cannabidiol
| 20件: 6 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
|
39 |
CNR2
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Cannabidiol
Cannabidiol
💬
|
Cannabidiol
| 20件: 6 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
|
40 |
FCER1A
💬
| 4件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Phospholipase D signaling pathway, Fc epsilon RI signaling pathway, Asthma | Omalizumab
Omalizumab
💬
|
Omalizumab
| 7件: 46 46, 53, 65, 98, 162, 226, 299 💬
|
41 |
GABRA
💬
| 7件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
42 |
GABRA
💬
| 7件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
43 |
GABRA
💬
| 7件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
44 |
GABRA
💬
| 7件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
45 |
GABRA
💬
| 7件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
46 |
GABRA
💬
| 7件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
47 |
GABRB
💬
| 7件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
48 |
GABRB
💬
| 7件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
49 |
GABRB
💬
| 7件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
50 |
GABRD
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
51 |
GABRE
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
52 |
GABRG
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
53 |
GABRG
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
54 |
GABRG
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
55 |
GABRP
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
56 |
GABRQ
💬
| 6件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | Fospropofol disodium
Fospropofol disodium
💬
|
Fospropofol
| 1件: 226 226 💬
|
57 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolate mofetil
Mycophenolate mofetil
💬
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
58 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolate sodium
Mycophenolate sodium
💬
|
Mycophenolic acid
| 37件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
|
59 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolic acid
Mycophenolic acid
💬
|
Mycophenolic acid
| 37件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
|
60 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolic acid
Mycophenolic acid
💬
|
Mycophenolic acid
| 37件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
|
61 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolate sodium
Mycophenolate sodium
💬
|
Mycophenolic acid
| 37件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
|
62 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolate mofetil hydrochloride
Mycophenolate mofetil hydrochloride
💬
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
63 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolate mofetil
Mycophenolate mofetil
💬
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
64 |
IMPDH
💬
| 2件: Purine metabolism Purine metabolism, Drug metabolism - other enzymes | Mycophenolate mofetil hydrochloride
Mycophenolate mofetil hydrochloride
💬
|
Mycophenolate mofetil
| 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
65 |
NGFB
💬
| 9件: MAPK signaling pathway MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Apoptosis, Neurotrophin signaling pathway, Inflammatory mediator regulation of TRP channels | Tanezumab
Tanezumab
💬
|
Tanezumab
| 2件: 226 226, 298 💬
|
66 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Triamcinolone hexacetonide
Triamcinolone hexacetonide
💬
|
Triamcinolone
| 10件: 35 35, 46, 53, 56, 70, 90, 96, 107, 226, 298 💬
|
67 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Triamcinolone diacetate
Triamcinolone diacetate
💬
|
Triamcinolone
| 10件: 35 35, 46, 53, 56, 70, 90, 96, 107, 226, 298 💬
|
68 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Triamcinolone
Triamcinolone
💬
|
Triamcinolone
| 10件: 35 35, 46, 53, 56, 70, 90, 96, 107, 226, 298 💬
|
69 |
NR3C1
💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction | Triamcinolone acetonide
Triamcinolone acetonide
💬
|
Triamcinolone
| 10件: 35 35, 46, 53, 56, 70, 90, 96, 107, 226, 298 💬
|
70 |
OPRD1
💬
| 5件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naltrexone
Naltrexone
💬
|
Naltrexone
| 12件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
|
71 |
OPRD1
💬
| 5件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Oxycodone hydrochloride
Oxycodone hydrochloride
💬
|
Oxycodone
| 6件: 6 6, 46, 70, 226, 231, 298 💬
|
72 |
OPRD1
💬
| 5件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naltrexone hydrochloride
Naltrexone hydrochloride
💬
|
Naltrexone
| 12件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
|
73 |
OPRD1
💬
| 5件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naloxone hydrochloride dihydrate
Naloxone hydrochloride dihydrate
💬
|
Naloxone
| 2件: 6 6, 226 💬
|
74 |
OPRD1
💬
| 5件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Oxycodone
Oxycodone
💬
|
Oxycodone
| 6件: 6 6, 46, 70, 226, 231, 298 💬
|
75 |
OPRD1
💬
| 5件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Oxycodone terephthalate
Oxycodone terephthalate
💬
|
Oxycodone
| 6件: 6 6, 46, 70, 226, 231, 298 💬
|
76 |
OPRD1
💬
| 5件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naloxone
Naloxone
💬
|
Naloxone
| 2件: 6 6, 226 💬
|
77 |
OPRD1
💬
| 5件: cGMP-PKG signaling pathway cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naloxone hydrochloride
Naloxone hydrochloride
💬
|
Naloxone
| 2件: 6 6, 226 💬
|
78 |
OPRK1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naltrexone hydrochloride
Naltrexone hydrochloride
💬
|
Naltrexone
| 12件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
|
79 |
OPRK1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naloxone
Naloxone
💬
|
Naloxone
| 2件: 6 6, 226 💬
|
80 |
OPRK1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naltrexone
Naltrexone
💬
|
Naltrexone
| 12件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
|
81 |
OPRK1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naloxone hydrochloride dihydrate
Naloxone hydrochloride dihydrate
💬
|
Naloxone
| 2件: 6 6, 226 💬
|
82 |
OPRK1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Oxycodone terephthalate
Oxycodone terephthalate
💬
|
Oxycodone
| 6件: 6 6, 46, 70, 226, 231, 298 💬
|
83 |
OPRK1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Naloxone hydrochloride
Naloxone hydrochloride
💬
|
Naloxone
| 2件: 6 6, 226 💬
|
84 |
OPRK1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Oxycodone hydrochloride
Oxycodone hydrochloride
💬
|
Oxycodone
| 6件: 6 6, 46, 70, 226, 231, 298 💬
|
85 |
OPRK1
💬
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling | Oxycodone
Oxycodone
💬
|
Oxycodone
| 6件: 6 6, 46, 70, 226, 231, 298 💬
|
86 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Tramadol
Tramadol
💬
|
Tramadol
| 4件: 46 46, 70, 226, 271 💬
|
87 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Oxycodone hydrochloride
Oxycodone hydrochloride
💬
|
Oxycodone
| 6件: 6 6, 46, 70, 226, 231, 298 💬
|
88 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Oxycodone terephthalate
Oxycodone terephthalate
💬
|
Oxycodone
| 6件: 6 6, 46, 70, 226, 231, 298 💬
|
89 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Oxycodone
Oxycodone
💬
|
Oxycodone
| 6件: 6 6, 46, 70, 226, 231, 298 💬
|
90 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Tramadol hydrochloride
Tramadol hydrochloride
💬
|
Tramadol
| 4件: 46 46, 70, 226, 271 💬
|
91 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Naltrexone hydrochloride
Naltrexone hydrochloride
💬
|
Naltrexone
| 12件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
|
92 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Naloxone hydrochloride
Naloxone hydrochloride
💬
|
Naloxone
| 2件: 6 6, 226 💬
|
93 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Naltrexone
Naltrexone
💬
|
Naltrexone
| 12件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬
|
94 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Naloxone hydrochloride dihydrate
Naloxone hydrochloride dihydrate
💬
|
Naloxone
| 2件: 6 6, 226 💬
|
95 |
OPRM1
💬
| 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Hormone signaling, Neuroactive ligand signaling, Estrogen signaling pathway, Morphine addiction | Naloxone
Naloxone
💬
|
Naloxone
| 2件: 6 6, 226 💬
|
96 |
OXTR
💬
| 5件: Calcium signaling pathway Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Hormone signaling, Oxytocin signaling pathway | Oxytocin
Oxytocin
💬
|
Oxytocin
| 8件: 6 6, 70, 72, 127, 168, 193, 206, 226 💬
|
97 |
P2RX3
💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Taste transduction | Gefapixant citrate
Gefapixant citrate
💬
|
Gefapixant
| 2件: 85 85, 226 💬
|
98 |
P2RX3
💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Neuroactive ligand signaling, Taste transduction | Gefapixant
Gefapixant
💬
|
Gefapixant
| 2件: 85 85, 226 💬
|
99 |
PDE1
💬
| 6件: Purine metabolism Purine metabolism, Calcium signaling pathway, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
100 |
PDE1
💬
| 6件: Purine metabolism Purine metabolism, Calcium signaling pathway, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
101 |
PDE1
💬
| 6件: Purine metabolism Purine metabolism, Calcium signaling pathway, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
102 |
PDE1
💬
| 6件: Purine metabolism Purine metabolism, Calcium signaling pathway, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
103 |
PDE1
💬
| 6件: Purine metabolism Purine metabolism, Calcium signaling pathway, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
104 |
PDE1
💬
| 6件: Purine metabolism Purine metabolism, Calcium signaling pathway, Olfactory transduction, Taste transduction, Renin secretion, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
105 |
PDE10
💬
| 3件: Purine metabolism Purine metabolism, cAMP signaling pathway, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
106 |
PDE10
💬
| 3件: Purine metabolism Purine metabolism, cAMP signaling pathway, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
107 |
PDE11
💬
| 3件: Purine metabolism Purine metabolism, Cushing syndrome, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
108 |
PDE11
💬
| 3件: Purine metabolism Purine metabolism, Cushing syndrome, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
109 |
PDE2A
💬
| 5件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway, Olfactory transduction, Aldosterone synthesis and secretion, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
110 |
PDE2A
💬
| 5件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway, Olfactory transduction, Aldosterone synthesis and secretion, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
111 |
PDE3A
💬
| 5件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway, cAMP signaling pathway, Renin secretion, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
112 |
PDE3A
💬
| 5件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway, cAMP signaling pathway, Renin secretion, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
113 |
PDE3B
💬
| 10件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway, cAMP signaling pathway, Apelin signaling pathway, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Glucagon signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
114 |
PDE3B
💬
| 10件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway, cAMP signaling pathway, Apelin signaling pathway, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Glucagon signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
115 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
116 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
117 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
118 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
119 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
120 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
121 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
122 |
PDE4
💬
| 4件: Purine metabolism Purine metabolism, cAMP signaling pathway, Parathyroid hormone synthesis, secretion and action, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
123 |
PDE5
💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway | Sildenafil
Sildenafil
💬
|
Sildenafil
| 14件: 6 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
|
124 |
PDE5
💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway | Sildenafil citrate
Sildenafil citrate
💬
|
Sildenafil
| 14件: 6 6, 46, 51, 85, 86, 113, 210, 211, 212, 225, 226, 278, 294, 299 💬
|
125 |
PDE7
💬
| 2件: Purine metabolism Purine metabolism, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
126 |
PDE7
💬
| 2件: Purine metabolism Purine metabolism, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
127 |
PDE7
💬
| 2件: Purine metabolism Purine metabolism, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
128 |
PDE7
💬
| 2件: Purine metabolism Purine metabolism, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
129 |
PDE8
💬
| 4件: Purine metabolism Purine metabolism, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
130 |
PDE8
💬
| 4件: Purine metabolism Purine metabolism, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
131 |
PDE8
💬
| 4件: Purine metabolism Purine metabolism, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | Flavoxate
Flavoxate
💬
|
Flavoxate
| 1件: 226 226 💬
|
132 |
PDE8
💬
| 4件: Purine metabolism Purine metabolism, Cortisol synthesis and secretion, Cushing syndrome, Morphine addiction | Flavoxate hydrochloride
Flavoxate hydrochloride
💬
|
Flavoxate
| 1件: 226 226 💬
|
133 |
PPP3C
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
134 |
PPP3C
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 42件: 11 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
|
135 |
PPP3C
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
136 |
PPP3C
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
137 |
PPP3C
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
138 |
PPP3C
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 42件: 11 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
|
139 |
PPP3C
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
140 |
PPP3C
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
141 |
PPP3C
💬
| 33件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 42件: 11 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
|
142 |
PPP3R
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 42件: 11 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
|
143 |
PPP3R
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
144 |
PPP3R
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Cyclosporine
Cyclosporine
💬
|
Cyclosporine
| 42件: 11 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
|
145 |
PPP3R
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
146 |
PPP3R
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
147 |
PPP3R
💬
| 32件: MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Cellular senescence, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, C-type lectin receptor signaling pathway, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Renin secretion, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Amphetamine addiction, Tuberculosis, Human cytomegalovirus infection, Human T-cell leukemia virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Human immunodeficiency virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Lipid and atherosclerosis | Tacrolimus
Tacrolimus
💬
|
Tacrolimus
| 33件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
148 |
PTGS1
💬
| 4件: Arachidonic acid metabolism Arachidonic acid metabolism, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | Ketorolac
Ketorolac
💬
|
Ketorolac
| 2件: 70 70, 226 💬
|
149 |
PTGS1
💬
| 4件: Arachidonic acid metabolism Arachidonic acid metabolism, Platelet activation, Serotonergic synapse, Regulation of lipolysis in adipocytes | Ketorolac tromethamine
Ketorolac tromethamine
💬
|
Ketorolac
| 2件: 70 70, 226 💬
|
150 |
PTGS2
💬
| 22件: Arachidonic acid metabolism Arachidonic acid metabolism, NF-kappa B signaling pathway, Efferocytosis, VEGF signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Leishmaniasis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Chemical carcinogenesis - DNA adducts, MicroRNAs in cancer, Small cell lung cancer | Ketorolac
Ketorolac
💬
|
Ketorolac
| 2件: 70 70, 226 💬
|
151 |
PTGS2
💬
| 22件: Arachidonic acid metabolism Arachidonic acid metabolism, NF-kappa B signaling pathway, Efferocytosis, VEGF signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Leishmaniasis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Chemical carcinogenesis - DNA adducts, MicroRNAs in cancer, Small cell lung cancer | Ketorolac tromethamine
Ketorolac tromethamine
💬
|
Ketorolac
| 2件: 70 70, 226 💬
|
152 |
SCN1A
💬
| 1件: Dopaminergic synapse Dopaminergic synapse | Lidocaine hydrochloride monohydrate
Lidocaine hydrochloride monohydrate
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
153 |
SCN1A
💬
| 1件: Dopaminergic synapse Dopaminergic synapse | Lidocaine
Lidocaine
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
154 |
SCN1A
💬
| 1件: Dopaminergic synapse Dopaminergic synapse | Lidocaine hydrochloride
Lidocaine hydrochloride
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
155 |
SCN1A
💬
| 1件: Dopaminergic synapse Dopaminergic synapse | Bupivacaine
Bupivacaine
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
156 |
SCN1A
💬
| 1件: Dopaminergic synapse Dopaminergic synapse | Bupivacaine hydrochloride
Bupivacaine hydrochloride
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
157 |
SCN2A
💬
| 1件: Taste transduction Taste transduction | Bupivacaine
Bupivacaine
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
158 |
SCN2A
💬
| 1件: Taste transduction Taste transduction | Bupivacaine hydrochloride
Bupivacaine hydrochloride
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
159 |
SCN2A
💬
| 1件: Taste transduction Taste transduction | Lidocaine hydrochloride monohydrate
Lidocaine hydrochloride monohydrate
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
160 |
SCN2A
💬
| 1件: Taste transduction Taste transduction | Lidocaine
Lidocaine
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
161 |
SCN2A
💬
| 1件: Taste transduction Taste transduction | Lidocaine hydrochloride
Lidocaine hydrochloride
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
162 |
SCN3A
💬
| 1件: Taste transduction Taste transduction | Lidocaine
Lidocaine
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
163 |
SCN3A
💬
| 1件: Taste transduction Taste transduction | Lidocaine hydrochloride
Lidocaine hydrochloride
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
164 |
SCN3A
💬
| 1件: Taste transduction Taste transduction | Bupivacaine
Bupivacaine
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
165 |
SCN3A
💬
| 1件: Taste transduction Taste transduction | Lidocaine hydrochloride monohydrate
Lidocaine hydrochloride monohydrate
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
166 |
SCN3A
💬
| 1件: Taste transduction Taste transduction | Bupivacaine hydrochloride
Bupivacaine hydrochloride
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
167 |
SCN5A
💬
| 1件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes | Bupivacaine hydrochloride
Bupivacaine hydrochloride
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
168 |
SCN5A
💬
| 1件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes | Bupivacaine
Bupivacaine
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
169 |
SCN5A
💬
| 1件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes | Lidocaine hydrochloride
Lidocaine hydrochloride
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
170 |
SCN5A
💬
| 1件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes | Lidocaine hydrochloride monohydrate
Lidocaine hydrochloride monohydrate
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
171 |
SCN5A
💬
| 1件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes | Lidocaine
Lidocaine
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
172 |
SCN9A
💬
| 1件: Taste transduction Taste transduction | Bupivacaine hydrochloride
Bupivacaine hydrochloride
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
173 |
SCN9A
💬
| 1件: Taste transduction Taste transduction | Lidocaine
Lidocaine
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
174 |
SCN9A
💬
| 1件: Taste transduction Taste transduction | Bupivacaine
Bupivacaine
💬
|
Bupivacaine
| 6件: 46 46, 53, 70, 96, 168, 226 💬
|
175 |
SCN9A
💬
| 1件: Taste transduction Taste transduction | Lidocaine hydrochloride
Lidocaine hydrochloride
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
176 |
SCN9A
💬
| 1件: Taste transduction Taste transduction | Lidocaine hydrochloride monohydrate
Lidocaine hydrochloride monohydrate
💬
|
Lidocaine
| 14件: 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
177 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Heparin sodium
Heparin sodium
💬
|
Heparin
| 10件: 47 47, 60, 65, 70, 79, 84, 107, 226, 280, 299 💬
|
178 |
SERPINC1
💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades | Heparin calcium
Heparin calcium
💬
|
Heparin
| 10件: 47 47, 60, 65, 70, 79, 84, 107, 226, 280, 299 💬
|
179 |
SLC6A2
💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle | Amitriptyline
Amitriptyline
💬
|
Amitriptyline
| 3件: 97 97, 226, 299 💬
|
180 |
SLC6A2
💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle | Amitriptyline hydrochloride
Amitriptyline hydrochloride
💬
|
Amitriptyline
| 3件: 97 97, 226, 299 💬
|
181 |
SLC6A2
💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle | Nortriptyline
Nortriptyline
💬
|
Nortriptyline
| 2件: 6 6, 226 💬
|
182 |
SLC6A2
💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle | Nortriptyline hydrochloride
Nortriptyline hydrochloride
💬
|
Nortriptyline
| 2件: 6 6, 226 💬
|
183 |
SLC6A4
💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle, Serotonergic synapse | Nortriptyline
Nortriptyline
💬
|
Nortriptyline
| 2件: 6 6, 226 💬
|
184 |
SLC6A4
💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle, Serotonergic synapse | Nortriptyline hydrochloride
Nortriptyline hydrochloride
💬
|
Nortriptyline
| 2件: 6 6, 226 💬
|
185 |
SLC6A4
💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle, Serotonergic synapse | Amitriptyline hydrochloride
Amitriptyline hydrochloride
💬
|
Amitriptyline
| 3件: 97 97, 226, 299 💬
|
186 |
SLC6A4
💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle, Serotonergic synapse | Amitriptyline
Amitriptyline
💬
|
Amitriptyline
| 3件: 97 97, 226, 299 💬
|
187 |
SNAP25
💬
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Insulin secretion | Prabotulinumtoxin A
Prabotulinumtoxin A
💬
|
Botulinum toxin type A
| 14件: 2 2, 5, 6, 7, 13, 15, 17, 47, 51, 70, 113, 149, 171, 226 💬
|
188 |
SNAP25
💬
| 2件: Synaptic vesicle cycle Synaptic vesicle cycle, Insulin secretion | Botulinum toxin type A
Botulinum toxin type A
💬
|
Botulinum toxin type A
| 14件: 2 2, 5, 6, 7, 13, 15, 17, 47, 51, 70, 113, 149, 171, 226 💬
|
189 |
TNF
💬
| 66件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Adalimumab
Adalimumab
💬
|
Adalimumab
| 21件: 19 19, 37, 38, 40, 41, 46, 55, 56, 84, 96, 97, 107, 151, 160, 162, 164, 222, 226, 269, 270, 271 💬
|
190 |
TNF
💬
| 66件: MAPK signaling pathway MAPK signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, Necroptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, C-type lectin receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, IL-17 signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Insulin resistance, Non-alcoholic fatty liver disease, AGE-RAGE signaling pathway in diabetic complications, Alcoholic liver disease, Type I diabetes mellitus, Alzheimer disease, Amyotrophic lateral sclerosis, Prion disease, Pathways of neurodegeneration - multiple diseases, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Yersinia infection, Leishmaniasis, Chagas disease, African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Human cytomegalovirus infection, Influenza A, Human papillomavirus infection, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection, Epstein-Barr virus infection, Human immunodeficiency virus 1 infection, Coronavirus disease - COVID-19, Proteoglycans in cancer, Asthma, Inflammatory bowel disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy, Dilated cardiomyopathy, Lipid and atherosclerosis, Fluid shear stress and atherosclerosis | Certolizumab pegol
Certolizumab pegol
💬
|
Certolizumab pegol
| 7件: 37 37, 46, 49, 96, 107, 226, 271 💬
|
191 |
TRPV1
💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels | Capsaicin
Capsaicin
💬
|
Capsaicin
| 4件: 2 2, 6, 86, 226 💬
|